Skip to main content

The complex between human IgE-Fc and two anti-IgE Fab fragments


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
D [auth I]ProQe5g64I1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)
C [auth H]ProQe5g64H1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)
F [auth M]ProQe5g64M1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)
E [auth L]ProQe5g64L1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)
BProQe5g64B1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)
AProQe5g64A1 A: alpha arraysX: POZ domainH: POZ domainT: POZ domainF: ProQECOD (v295.2)

Domain Annotation: CATH CATH Database Homepage

IMGT Antibody Annotation IMGT Database Homepage

ChainProtein NameDescriptionOrganism NameGene Allele Name(s)Domain Name(s)Receptor TypeReceptor DescriptionProvenance Source
C [auth H],
D [auth I]
anti-IgE Fab VH-CH1 Homo sapiens (human) IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ3*01, IGHG1*01, IGHG1*02, IGHG1*04, IGHG1*05 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202643-0)
E [auth L],
F [auth M]
anti-IgE Fab L-KAPPA Homo sapiens (human) IGKV1-39*01, IGKV1D-39*01, IGKJ1*01, IGKJ2*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202643-0)
A, B
Fc IgE (epsilon) CH2-CH3 Homo sapiens (human) IGHE*01, IGHE*02, IGHE*04 C-DOMAIN CH2, C-DOMAIN CH3, C-DOMAIN CH4 IG CH2-CH3 IMGT (202643-0)

SAbDab2 Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
C [auth H],
D [auth I]
Heavy ChainIGHV3 -IG EPSILON CHAIN C REGIONSAbDab (2026-11-06)
E [auth L],
F [auth M]
Light ChainIGKV1 KappaIG EPSILON CHAIN C REGIONSAbDab (2026-11-06)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
C [auth H],
D [auth I]
Omalizumab IGHETherapeutic SAbDab (2026-11-06)
E [auth L],
F [auth M]
Omalizumab IGHETherapeutic SAbDab (2026-11-06)